Patents by Inventor Ian J. Massey

Ian J. Massey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • mTORC modulators and uses thereof
    Patent number: 11702429
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: July 18, 2023
    Assignee: AEOVIAN PHARMACEUTICALS, INC.
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • MTORC MODULATORS AND USES THEREOF
    Publication number: 20230080483
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Application
    Filed: December 16, 2021
    Publication date: March 16, 2023
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • MTORC MODULATORS AND USES THEREOF
    Publication number: 20230013344
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Application
    Filed: May 21, 2021
    Publication date: January 19, 2023
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • mTORC modulators and uses thereof
    Patent number: 11230557
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: January 25, 2022
    Assignee: Aeovian Pharmaceuticals, Inc.
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • mTORC modulators and uses thereof
    Patent number: 11021492
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: June 1, 2021
    Assignee: AEOVIAN PHARMACEUTICALS, INC.
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • MTORC MODULATORS AND USES THEREOF
    Publication number: 20210008041
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 14, 2021
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe
  • MTORC MODULATORS AND USES THEREOF
    Publication number: 20210002300
    Abstract: Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventors: Stelios T. Tzannis, Ian J. Massey, Alexandre Froidbise, Guillaume Eppe